SIRONA 3-Year Results: Sirolimus-Coated Balloon Shows Higher Freedom From Repeat Revascularization
San Francisco Chronicle · PR Newswire ·
Three-year results from the randomized SIRONA trial show that patients with femoropopliteal artery disease treated with the MagicTouch PTA (Concept Medical) sirolimus-coated balloon (SCB) were
Read the full story at San Francisco Chronicle · All coverage of this story